Registration of securities issued in business combination transactions

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.19.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 6 Months Ended 12 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Sep. 30, 2018
Sep. 30, 2017
OPERATING ACTIVITIES:        
Net loss $ (5,414,100) $ (5,429,000) $ (10,333,100) $ (7,112,800)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization 60,300 57,500 117,900 48,700
Change in provision for doubtful accounts 6,300 1,200 800
Stock based compensation 775,300 593,000 1,588,300 2,086,000
Common stock issued to vendors for services (52,600) (25,800) (201,920) (173,000)
Accretion of debt discount and non-cash interest expense 46,700 35,500 82,300
Changes in operating assets and liabilities:        
Accounts receivable (97,400) (156,200) (500) (1,400)
Prepaid expenses and other assets (800) (97,200) (91,500) (12,100)
Accounts payable and accrued liabilities 559,600 112,400 (432,700) 301,500
Deferred revenue (7,600) 125,000 113,800
Deferred compensation 183,000 (8,300) (285,900) (275,000)
Net cash used in operating activities (3,836,100) (4,740,300) (9,038,680) (4,792,100)
INVESTING ACTIVITIES:        
Purchase of furniture/property and equipment (9,100) (55,200) (55,200) (127,900)
Investment in Arcadian     (190,000)
Payment for acquisition of business, net of cash acquired (306,600) (306,600)
Loan Advance - Plotkin     (159,500)
Purchase of intangible assets     (2,100)
Net cash used in investing activities (9,100) (361,800) (361,800) (479,500)
FINANCING ACTIVITIES:        
Principal payments on capital lease (600) (600) (2,600) (1,200)
Principal payments on long-term debt     (37,000)
Principal payments on note payable (17,500) (34,100) (36,200) (56,200)
Proceeds from Aspire Capital purchase agreements     4,260,210 145,000
Proceeds from sale of preferred stock and common stock warrants     2,037,100
Proceeds from sale of common stock, net of costs 1,811,800 2,100,000 930,435 2,981,300
Proceeds from public offering     7,482,100
Proceeds from stock options exercised     54,235
Deferred offering costs     (148,600)
Net cash provided by financing activities 1,793,700 2,065,300 7,206,180 10,402,400
NET INCREASE (DECREASE) IN CASH (2,051,500) (3,036,800) (2,194,300) 5,130,800
CASH AND CASH EQUIVALENTS - BEGINNING OF THE PERIOD 3,254,700 5,449,000 5,449,000 318,200
CASH AND CASH EQUIVALENTS - END OF THE PERIOD 1,203,200 2,412,200 3,254,700 5,449,000
Cash paid during the period for:        
Interest 2,000 4,700 8,200 6,600
Income taxes 2,300 1,900 1,900 2,600
Non-cash financing and investing activities        
Long-term borrowings assumed in business combination $ 651,700 651,700
Commitment shares issued to Aspire Capital as offering cost     795,000 708,000
Investment in Arcadian 1,000 shares at $5.90 per share of common stock     $ 5,900